Every step we take together, whether that’s in the hospital, clinic or in the home, we are touching lives and providing new hope for patients.
Baxter has been a pioneer in the treatment and management of end-stage kidney disease for over 85 years. Today, our advanced products for both hemodialysis and peritoneal dialysis are transforming renal care, while our innovative capabilities within acute kidney injury are breaking ground in the delivery of continuous renal replacement therapy.
It’s why you can rely on us to be the type of dedicated partner who understands the challenges you face throughout the continuum of care, whether you are a patient or healthcare professional.
Explore our Therapies
As a leader in CRRT, our approach to technology helps optimize clinical success, with a comprehensive offering in advanced therapies.
Expanded Hemodialysis (HDx) Therapy
Introducing Expanded Hemodialysis (HDx) therapy: The next evolution in hemodialysis treatment that brings us one step closer to the natural kidney through superior removal of an expanded range of conventional/large middle molecules (up to 45,000 Da).1 De Novo Granted-NOW AVAILABLE.
Hemodialysis (HD) Therapy
We provide products that help improve the quality of treatments and simplify therapy delivery for the diverse and growing population of end-stage renal disease patients.
Peritoneal Dialysis (PD) Therapy
Our comprehensive PD product offerings include the only two-way remote patient management system that helps clinicians monitor historical treatment data and enables patients to dialyze at home with confidence.